DRUG BUREAU CHIEF DEFENDS FDA ON PAYOFFS

The head of the US Food and Drug Administration (FDA) said July 11 that generic drug companies are partly to blame for a payoff scandal in his agency. After 1984 reforms made it easier to put generic drugs on the market, ``many generic drug companies did not hesitate to exert tremendous pressure on FDA drug reviewers,'' FDA Commissioner Frank Young told a House subcommittee.

A year-long federal grand jury probe has so far led to charges of criminal wrongdoing against three FDA employees and three generic drug company executives.

About these ads
Sponsored Content by LockerDome

We want to hear, did we miss an angle we should have covered? Should we come back to this topic? Or just give us a rating for this story. We want to hear from you.

Loading...

Loading...

Loading...

Save for later

Save
Cancel

Saved ( of items)

This item has been saved to read later from any device.
Access saved items through your user name at the top of the page.

View Saved Items

OK

Failed to save

You reached the limit of 20 saved items.
Please visit following link to manage you saved items.

View Saved Items

OK

Failed to save

You have already saved this item.

View Saved Items

OK